scispace - formally typeset
J

Julie E. Norville

Researcher at Harvard University

Publications -  15
Citations -  12237

Julie E. Norville is an academic researcher from Harvard University. The author has contributed to research in topics: Genome & Cas9. The author has an hindex of 10, co-authored 15 publications receiving 10965 citations. Previous affiliations of Julie E. Norville include Massachusetts Institute of Technology & Vassar College.

Papers
More filters
Journal ArticleDOI

RNA-Guided Human Genome Engineering via Cas9

TL;DR: The type II bacterial CRISPR system is engineer to function with custom guide RNA (gRNA) in human cells to establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.
Journal ArticleDOI

Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

TL;DR: The use of type II bacterial CRISPR-Cas system in Saccharomyces cerevisiae for genome engineering provides foundations for a simple and powerful genome engineering tool for site-specific mutagenesis and allelic replacement in yeast.
Journal ArticleDOI

Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9

TL;DR: Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9 is described.
Journal ArticleDOI

Integration of Photosynthetic Protein Molecular Complexes in Solid-State Electronic Devices

TL;DR: In this paper, the integration of electrically active photosynthetic protein−molecular complexes in solid-state devices was demonstrated, achieving photodetectors and photovoltaic cells with internal quantum efficiencies of approximately 12%.
Journal ArticleDOI

Biocontainment of genetically modified organisms by synthetic protein design

TL;DR: This work computationally redesign essential enzymes in the first organism possessing an altered genetic code to confer metabolic dependence on non-standard amino acids for survival, providing a foundation for safer GMOs that are isolated from natural ecosystems by a reliance on synthetic metabolites.